Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine receptor D3 | Starlite/ChEMBL | No references |
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | dopamine receptor D3 | 400 aa | 392 aa | 19.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0079 | 0.1175 | 1 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0032 | 0.021 | 0.0256 |
Mycobacterium tuberculosis | Probable epoxide hydrolase EphA (epoxide hydratase) (arene-oxide hydratase) | 0.0349 | 0.6675 | 1 |
Echinococcus granulosus | roundabout 2 | 0.005 | 0.0584 | 0.0687 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0513 | 1 | 1 |
Echinococcus multilocularis | Immunoglobulin | 0.0032 | 0.021 | 0.0232 |
Brugia malayi | Thioredoxin reductase | 0.0031 | 0.0202 | 0.0183 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0426 | 0.8229 | 1 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0042 | 0.042 | 0.0487 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0263 | 0.0243 |
Trypanosoma brucei | trypanothione reductase | 0.0031 | 0.0202 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0426 | 0.8229 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0071 | 0.1014 | 0.1254 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0079 | 0.1175 | 0.1503 |
Plasmodium falciparum | glutathione reductase | 0.0031 | 0.0202 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0032 | 0.021 | 0.0191 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Schistosoma mansoni | Protein orai-1 | 0.0303 | 0.5742 | 0.6978 |
Schistosoma mansoni | cell adhesion molecule | 0.0042 | 0.042 | 0.051 |
Schistosoma mansoni | vesicular amine transporter | 0.0032 | 0.021 | 0.0256 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0031 | 0.0202 | 0.0222 |
Echinococcus granulosus | defective proboscis extension response | 0.0032 | 0.021 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0211 | 0.0009 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0032 | 0.021 | 0.0232 |
Echinococcus multilocularis | Immunoglobulin | 0.0032 | 0.021 | 0.0232 |
Echinococcus multilocularis | tumor protein p63 | 0.0216 | 0.3958 | 0.4797 |
Brugia malayi | glutathione reductase | 0.0031 | 0.0202 | 0.0183 |
Leishmania major | trypanothione reductase | 0.0031 | 0.0202 | 0.5 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0071 | 0.1014 | 0.1254 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0263 | 0.0062 |
Echinococcus multilocularis | roundabout 2 | 0.005 | 0.0584 | 0.0687 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0031 | 0.0202 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0584 | 0.039 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Schistosoma mansoni | nephrin | 0.004 | 0.0374 | 0.0455 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.0584 | 0.0566 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Schistosoma mansoni | Protein orai-1 | 0.0303 | 0.5742 | 0.6978 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0079 | 0.1175 | 0.1503 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0426 | 0.8229 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Echinococcus granulosus | tumor protein p63 | 0.0216 | 0.3958 | 0.4797 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0031 | 0.0202 | 0.0222 |
Plasmodium vivax | glutathione reductase, putative | 0.0031 | 0.0202 | 0.5 |
Echinococcus multilocularis | neuroglian | 0.004 | 0.0374 | 0.0432 |
Echinococcus granulosus | Immunoglobulin | 0.0032 | 0.021 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.042 | 0.0222 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0078 | 0.1148 | 0.1375 |
Schistosoma mansoni | hypothetical protein | 0.0078 | 0.1148 | 0.1396 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Brugia malayi | hypothetical protein | 0.0032 | 0.021 | 0.0191 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0584 | 0.0389 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0479 | 0.9313 | 1 |
Echinococcus granulosus | twitchin | 0.004 | 0.0374 | 0.0432 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0071 | 0.1014 | 0.1254 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0071 | 0.1014 | 0.1254 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0022 | 0.002 | 0.0024 |
Loa Loa (eye worm) | hypothetical protein | 0.0303 | 0.5742 | 0.5655 |
Mycobacterium ulcerans | epoxide hydrolase EphA | 0.0349 | 0.6675 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0079 | 0.1175 | 0.1503 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0032 | 0.0211 | 0.0256 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.0584 | 0.039 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0584 | 0.0389 |
Echinococcus granulosus | calcium release activated calcium channel | 0.0303 | 0.5742 | 0.6971 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0032 | 0.021 | 0.0191 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0084 | 0.1275 | 0.1529 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0071 | 0.1014 | 0.1254 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0031 | 0.0202 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0031 | 0.0202 | 0.5 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0032 | 0.021 | 0.0256 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0084 | 0.1275 | 0.155 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0078 | 0.1148 | 0.1375 |
Mycobacterium tuberculosis | Probable reductase | 0.0071 | 0.1014 | 0.1254 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0263 | 0.032 |
Schistosoma mansoni | thyroid hormone receptor | 0.0084 | 0.1275 | 0.155 |
Brugia malayi | hypothetical protein | 0.0303 | 0.5742 | 0.5734 |
Echinococcus multilocularis | calcium release activated calcium channel | 0.0303 | 0.5742 | 0.6971 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.002 | 0.0024 |
Onchocerca volvulus | 0.0468 | 0.909 | 0.9756 | |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0031 | 0.0202 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.0584 | 0.0566 |
Echinococcus granulosus | neuroglian | 0.004 | 0.0374 | 0.0432 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = -7.8 | Ability to displace [125I]-sulpiride from human Dopamine receptor D3, expressed in CHO cells | ChEMBL. | No reference |
Ki (binding) | = -5.8 | Ability to displace [125I]-sulpiride from human Dopamine receptor D2, expressed in CHO cells | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.